In the last years, DS/DR methods allowed both an in depth understanding of SMA pathological mechanisms and the identification of therapeutic approaches, including enhancing SMN function and regulating the SMN exon seven splicing. Here, SMN1 is linked to proximal spinal muscular atrophy.